Business profile

Next Biomed Therapies Oy

Next Biomed Therapies Oy's registered office is Helsingfors. It is a limited company. The company was established on 1999-10-21. It operates in the industry of manufacture of other medical and dental instruments and supplies. In its latest retained statement for 2025-12-31, revenue was €58,521 and operating profit was -€29,070.

Claim profileContact details
Business ID 1562366-5ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
1562366-5
Sector
Manufacture of other medical and dental instruments and supplies
Municipality
Helsingfors
Company form
Limited company
Registration date
1999-10-21
Business ID registration date
1999-11-04
Business status
Valid
Profile ownership
Unclaimed company profile
Data source
Public registry data

Contact and location summary

Visiting address: Viikinkaari 6, 00790, Helsingfors

About Next Biomed Therapies Oy

Financial position and key figures for the company.

Next Biomed Therapies Oy's location municipality is Helsingfors. It is a limited company. The company was established on 1999-10-21. It operates in the industry of manufacture of other medical and dental instruments and supplies. In its latest retained statement for 2025-12-31, revenue was €58,521 and operating profit was -€29,070. The latest retained financial statement for 2025-12-31 shows revenue of €58,521 and profit for the financial year of -€29,281. Based on the latest retained statement, revenue growth was -55.0%, operating margin was -49.7%, and equity ratio was +83.4%.

Financial highlights

Key figures from the latest financial period.

Open full statement
Latest financial period

2025-12-31

Imported periods4
PRH parsed2
Profile sourcePRH/XBRL financial statement
Derived indicators
Revenue growth-55.0%
Operating margin-49.7%
Equity ratio83.4%
Balance-sheet contextLatest retained period snapshot
Cash and bank€30,206Previous: €67,016
Retained earnings-€222,676Previous: -€260,010
Equity€44,596Previous: €79,877
Liabilities€8,889Previous: €10,237
Current assets€39,637Previous: €79,969
Current liabilities€8,889Previous: €10,237
Revenue trend2 periods
€129,983
2024-12-31
€58,521
2025-12-31
Operating profit (loss) trend2 periods
€43,398
2024-12-31
-€29,070
2025-12-31
Profit (loss) for the financial year trend2 periods
€43,334
2024-12-31
-€29,281
2025-12-31
Assets trend2 periods
€90,114
2024-12-31
€53,485
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.

Equity ratioGood
100/100 · Declining
83.4 %2024-12-31: 88.6 %
Current ratioGood
100/100 · Declining
3.40x2024-12-31: 6.55x
Operating profit marginWeak
0/100 · Declining
-49.7 %2024-12-31: 33.4 %
Ratio history
Ratio2024-12-312025-12-31
Equity ratio88.6 %83.4 %
Current ratio6.55x3.40x
Operating profit margin33.4 %-49.7 %

Registry status and identifiers

Verified registry memberships and identifiers from the latest retained YTJ snapshot.

YTJ statusValid
Trade RegisterRegistered
Business ID1562366-5
VAT IDFI15623665
EU IDFIFPRO.1562366-5
MunicipalityHelsingfors
Current registered entries
1999-10-21Registered in Patent and Registration Office (Trade Register)
1999-11-04Registered in Tax Administration (Tax Administration)
2015-01-02Registered in Tax Administration (Employer Register)
2015-01-02VAT-liable for business activity in Tax Administration (VAT Register)
2015-01-07Registered in Tax Administration (Prepayment Register)
2022-03-01VAT-obliged for the transfer of rights to use immovable property in Tax Administration (VAT Register)

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Financial data includedNot a credit decision
B1
StableNext Biomed Therapies Oy
Updated2026-08-29
ConfidenceHigh
Score65/100

The grade can use open digital financial statement data together with registry signals.

Risk context

When open digital financial statements are unavailable, BUSINESS.fi shows registry, industry, and regional context.

Industry riskmedium
57/100

Industry context is medium based on normalized open statistical inputs.

Age and continuityVakiintunut
90/100

The company has about 26 years of registry continuity.

Registry and status signalsVakaa
83/100

Registry history, filing recency, and active register markings are still limited or mixed.

Registry timeline

Trade register notifications shown on a timeline.

16 register eventsLatest event: 2026-02-19

Financial statements availability

Available statement periods and links into the retained/parsible financial statement surfaces. Use the latest statement page for deeper line-item detail.

4 financial statement periodsLatest financial period: 2025-12-31

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

Next Biomed Therapies Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.